Qube Research & Technologies (QRT)
ALT icon

Qube Research & Technologies (QRT)’s Altimmune ALT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-178,697
Closed -$465K – 4310
2023
Q3 		$465K Sell
178,697
-731,542
-80% -$2.1M ﹤0.01% 2060
2023
Q2 		$3.21M Buy
910,239
+227,559
+33% +$1.02M 0.01% 854
2023
Q1 		$2.88M Buy
682,680
+670,035
+5,299% +$7.96M 0.01% 853
2022
Q4 		$208K Sell
12,645
-21,934
-63% -$246K ﹤0.01% 1795
2022
Q3 		$442K Buy
+34,579
New +$511K ﹤0.01% 1514
2021
Q2 		– Sell
-17,645
Closed -$249K – 2221
2021
Q1 		$249K Sell
17,645
-56,713
-76% -$917K ﹤0.01% 1552
2020
Q4 		$839K Buy
74,358
+59,469
+399% +$701K 0.01% 933
2020
Q3 		$197K Buy
+14,889
New +$298K ﹤0.01% 1400

Other funds holding ALT

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ALT Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Altimmune (ALT) in Q4 2023, closing a stake of 178,697 shares — an estimated $465K sold.

Qube Research & Technologies (QRT) first reported a position in ALT in Q3 2020 and held it in 8 quarters. The position peaked at $3.21M in Q2 2023. 143 funds tracked by Wall St. Rank hold ALT as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining Altimmune position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 178,697 Altimmune shares in Q4 2023, an estimated $465K.
  • Qube Research & Technologies (QRT) first reported a position in Altimmune in Q3 2020 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Altimmune position peaked at $3.21M in Q2 2023.
  • 143 funds tracked by Wall St. Rank held Altimmune as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.